Organogenesis Holdings Inc.

Organogenesis Holdings Inc.verified

ORGO

Price:

$3.195

Market Cap:

$401.69M

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediat...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-01-05

Stock Exchange

NASDAQ

Ticker

ORGO

The Current Ratio as of December 2024 (TTM) for Organogenesis Holdings Inc. (ORGO) is 3.09

According to Organogenesis Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.09. This represents a change of 8.70% compared to the average of 2.84 of the last 4 quarters.

Organogenesis Holdings Inc. (ORGO) Historical Current Ratio (quarterly & annually)

How has ORGO Current Ratio performed in the past?

The mean historical Current Ratio of Organogenesis Holdings Inc. over the last ten years is 1.96. The current 3.09 Current Ratio has changed 15.65% with respect to the historical average. Over the past ten years (40 quarters), ORGO's Current Ratio was at its highest in in the June 2017 quarter at 7.02. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

1.96

Median

2.56

Minimum

0.07

Maximum

3.00

Organogenesis Holdings Inc. (ORGO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Organogenesis Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.33%

Maximum Annual Current Ratio = 3.00

Minimum Annual Increase = -97.50%

Minimum Annual Current Ratio = 0.07

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.80-5.79%
20222.977.20%
20212.778.30%
20202.5621.87%
20192.1095.72%
20181.071.33%
20170.07-97.50%
20163.00891.59%

Organogenesis Holdings Inc. (ORGO) Average Current Ratio

How has ORGO Current Ratio performed in the past?

The current Current Ratio of Organogenesis Holdings Inc. (ORGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.84

5-year avg

2.64

10-year avg

1.96

Organogenesis Holdings Inc. (ORGO) Current Ratio vs. Peers

How is ORGO’s Current Ratio compared to its peers?

Organogenesis Holdings Inc.’s Current Ratio is greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Mallinckrodt plc (2.74), greater than Lucy Scientific Discovery Inc. (0.38), greater than Alimera Sciences, Inc. (2.79), greater than Lifecore Biomedical, Inc. (1.83), greater than RedHill Biopharma Ltd. (0.84), less than Taro Pharmaceutical Industries Ltd. (3.61), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Adamis Pharmaceuticals Corporation (0.58), less than Alpha Teknova, Inc. (4.73), less than Guardion Health Sciences, Inc. (16.67), greater than Petros Pharmaceuticals, Inc. (0.85), less than Alkermes plc (3.45), less than Neurocrine Biosciences, Inc. (4.37), less than Intra-Cellular Therapies, Inc. (7.66), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Dynavax Technologies Corporation (13.23),

Build a custom stock screener for Organogenesis Holdings Inc. (ORGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organogenesis Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organogenesis Holdings Inc. (ORGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organogenesis Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Organogenesis Holdings Inc.'s Current Ratio?

How is the Current Ratio calculated for Organogenesis Holdings Inc. (ORGO)?

What is the highest Current Ratio for Organogenesis Holdings Inc. (ORGO)?

What is the 3-year average Current Ratio for Organogenesis Holdings Inc. (ORGO)?

What is the 5-year average Current Ratio for Organogenesis Holdings Inc. (ORGO)?

How does the current Current Ratio for Organogenesis Holdings Inc. (ORGO) compare to its historical average?